Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

Overview of attention for article published in The Lancet, August 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Altmetric has seen 4 news stories from 1 outlets.

Rheumatology > Arthritis Unacceptable levels of pain remained after 2 years of combination therapy, despite biomarker…

Rheumatology > Arthritis Outcomes favored methotrexate plus a TNF inhibitor versus methotrexate plus hydroxychloroquine and…

Action Points The combination of methotrexate, sulfasalazine, and hydroxychloroquine is similar in efficacy and less costly…

(MedPage Today) -- Worse patterns of disease for both rheumatoid arthritis and systemic lupus erythematosus were seen among…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.